Leadership: Page 13
-
Podcast
Woman of the Week: Glympse Bio’s Dr. Tram Tran
How the chief medical officer of the emerging diagnostic company is using the patient perspective as a guiding light.
By Taren Grom • Aug. 24, 2022 -
Making Moves
Moderna, Eli Lilly and Schrödinger seek to boost financial and people strategies with key new hires
How the latest personnel shifts are impacting each company and the industry at large.
By Karissa Waddick • Aug. 24, 2022 -
Trendline
Commercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
PharmaVoice 100
The story behind the PharmaVoice 100
Taren Grom, our founding editor and the feature’s originator, explains how the coveted PharmaVoice 100 awards got its start and what makes it stand out in the industry.
By Meagan Parrish • Aug. 23, 2022 -
As pharma M&A ramps up, U.S. execs are bullish on more deals
What top executives at Merck, Pfizer and more are saying about M&A as they move into the second half of the year.
By Michael Gibney • Aug. 11, 2022 -
Podcast
Woman of the Week: COTA’s Miruna Sasu
Miruna Sasu is on a mission to use real world data to help wipe out cancer. She believes this audacious goal is within reach, and as president and CEO of COTA, she is inspiring her team to create a “path to care” for oncology patients.
By Taren Grom • Aug. 10, 2022 -
Are Big Pharma CEOs earning their pay?
While compensation packages at the top may not always reflect value, it’s not necessarily an industrywide problem.
By Kelly Bilodeau • Aug. 8, 2022 -
Podcast
Woman of the Week: Alloy Therapeutics’ Heather Schwoebel
The CBO and COO is leaning on her experience navigating the unknown to turn Alloy into an innovation multiplier.
By Taren Grom • Aug. 3, 2022 -
Making Moves
Editas, Real Chemistry and Compass blaze new trails with pivotal C-suite hires
How these latest executive personnel changes are impacting the industry.
By Karissa Waddick • Aug. 3, 2022 -
Q&A
How a speech analysis tool could transform diagnosis and research for Alzheimer’s and beyond
WinterLight’s machine learning platform assesses speech to more accurately identify neurodegenerative diseases.
By Kim Ribbink • Aug. 1, 2022 -
What’s next for Biogen? Here’s what executives are saying
A trickling launch for Aduhelm and a middling earnings report give Biogen executives a lot to talk about. Is there hope?
By Michael Gibney • July 27, 2022 -
Podcast
Woman of the Week: Applied BioMath's Katie Williams
The 2022 president of Women in Bio is equal parts math and gender parity evangelist.
By Taren Grom • July 27, 2022 -
With big changes ahead for J&J and Novartis, here's what the companies' execs are talking about
Both J&J and Novartis are making — or considering — big shifts in their fundamental company makeup.
By Michael Gibney • July 21, 2022 -
Making Moves
Making moves: Agios, BeiGene, Biocom California and more announce new key hires
The latest executive personnel changes from around the industry.
By Karissa Waddick • July 18, 2022 -
Sponsored by Avant Healthcare
Digital Opinion Leader deep-dive: the sharer
Learn about Digital Opinion Leaders who curate tailored content experiences and provide value to their followers.
July 18, 2022 -
Q&A // First 90 Days
Anjarium Biosciences’ CEO on its next-gen gene therapies
Stephen Yoo aims to build on the buzz around the company’s leading-edge gene therapy tech.
By Kim Ribbink • July 15, 2022 -
Q&A
Janssen extends LGBTQ mental health outreach beyond Pride Month
The pharma giant’s ‘Depression looks like me’ campaign assembles a ‘one stop shop’ of resources to help combat high rates of severe depression in the LGBTQ community.
By Karissa Waddick • July 14, 2022 -
Podcast
Woman of the Week: Kura Oncology's Kirsten Flowers
How the chief commercial and corporate strategy officer is embracing a ‘full-cup’ philosophy to build a better leadership toolbox.
By Taren Grom • July 13, 2022 -
Profile
The power of the underdog: A rare disease nonprofit working to help patients win against the odds
Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.
By Alexandra Pecci • July 13, 2022 -
Q&A
The CEO of Dr. Reddy's N. America is using 'controlled explosions' to keep the generics giant growing
Marc Kikuchi weighs in on the company’s plans to pump up its pipeline and sales in the coming years.
By Meagan Parrish • July 7, 2022 -
Podcast
Woman of the Week: CinCor Pharma's Terry Coelho
From M&Ms to biotech, the chief financial officer's sweet tooth for taking risks is paying off.
By Taren Grom • July 6, 2022 -
Podcast
Woman of the Week: Novartis' Marie-France Tschudin
How the chief commercial officer and president of innovative medicines international plans to fuel growth and productivity at the company.
By Taren Grom • June 29, 2022 -
Making Moves
Making moves: Walgreens, Merck, eClinical Solutions and more announce key new hires
The latest personnel changes from around the industry.
By Karissa Waddick • June 29, 2022 -
Q&A
The scientist's struggle: Lessons from the journey of mRNA pioneers Katalin Karikó and Drew Weissman
The two Penn Medicine researchers whose work brought the mRNA vaccines into COVID-19 fruition want to see the pharma world embrace early science.
By Michael Gibney • June 29, 2022 -
Profile
From vineyards to antivirals, Gilly Regev brings creative thinking to science
The CEO of SaNOtize is tapping into outside-the-box innovation to develop a nitric oxide-delivery platform to treat and prevent COVID-19.
By Alexandra Pecci • June 27, 2022 -
4 tips for landing your next C-suite role in pharma
Even execs get the blues — and when they’re ready for a fresh start, Leslie Loveless, CEO of Slone Partners, says these dos and don’ts could make or break their next job move.
By Meagan Parrish • June 23, 2022